B. Coignard

17.0k citations
80 papers · 4.3k · 4 hit papers · h-index 30

Impact in

    • Antibiotic Use and Resistance
    • Clostridium difficile and Clostridium perfringens research
    • Antifungal resistance and susceptibility
    • Viral gastroenteritis research and epidemiology
    • Antimicrobial Resistance in Staphylococcus

Papers in

    • Clostridium difficile and Clostridium perfringens research 11
    • Antimicrobial Resistance in Staphylococcus 9
    • Infection Control in Healthcare 6
    • Urinary Tract Infections Management 5

B. Coignard

77 papers receiving 4.2k citations

B. Coignard's Hit Papers

Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024 2024 · 51 citations
510+6+13Years since publication200400600

Peers

B. Coignard
Comparison fields: 5 of 134
  • Applied Microbiology and Biotechnology 344
  • Infectious Diseases 2.5k
  • Molecular Medicine 557
  • Critical Care and Intensive Care Medicine 392
  • Epidemiology 1.5k
Replace Linda M. Mundy with:
Linda M. Mundy United States
Joelle Nadle United States
Susan Whittier United States
Carlene A. Muto United States
Wendy Bamberg United States
Tony M. Korman Australia
Ellen Jo Baron United States
José Mensa Spain
Mary‐Claire Roghmann United States
Meghan Maloney United States
B. Coignard relative to Linda M. Mundy United States Linda M. Mundy's profile →
Citations per field
00.5×1.5×2.1×
Linda M. Mundy · 1×
Citations per year

Countries citing papers authored by B. Coignard

Since Specialization
Citations

This map shows the geographic impact of B. Coignard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Coignard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Coignard more than expected).

Fields of papers citing papers by B. Coignard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Coignard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Coignard. The network helps show where B. Coignard may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Coignard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Coignard Line = papers co-authored together B. Coignard links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Emergence of Clostridium difficile-associated disease in North America and Europe
Hit paper breakdown →
2006720
2
The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use
Hit paper breakdown →
2012615
3
Recommendations for Surveillance of Clostridium difficile–Associated Disease
Hit paper breakdown →
2007491
4 2014316
5 2011260
6 2010134
7 2009110
8 200695
9 200892
10 200674
11 201174
12 200964
13 201263
14 201662
15 201660
16 201459
17 201956
18 201354
19
Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024
Hit paper breakdown →
202451
20 201148

About B. Coignard

B. Coignard is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine, having authored 80 papers that have together received 4.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (19 papers), Antibiotic Use and Resistance (15 papers), Clostridium difficile and Clostridium perfringens research (11 papers), Nosocomial Infections in ICU (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Bacterial Identification and Susceptibility Testing (9 papers), Infection Control in Healthcare (6 papers) and Urinary Tract Infections Management (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (344 citations), Infectious Diseases (2.5k citations), Molecular Medicine (557 citations), Critical Care and Intensive Care Medicine (392 citations) and Epidemiology (1.5k citations). B. Coignard has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Ed J. Kuijper, Peet Tüll, Yann Le Strat, Preeta K. Kutty, L. Clifford McDonald, Xiaoyan Song, Teresa Horan, Erik R. Dubberke, Olivier Lortholary and Françoise Dromer. Their work appears in journals such as Eurosurveillance, Infection Control and Hospital Epidemiology, Clinical Microbiology and Infection, Journal of Hospital Infection and Emerging infectious diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact